0001104659-22-010638.txt : 20220202 0001104659-22-010638.hdr.sgml : 20220202 20220202091014 ACCESSION NUMBER: 0001104659-22-010638 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20220202 FILED AS OF DATE: 20220202 DATE AS OF CHANGE: 20220202 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Quipt Home Medical Corp. CENTRAL INDEX KEY: 0001540013 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40413 FILM NUMBER: 22581690 BUSINESS ADDRESS: STREET 1: 1019 TOWN DRIVE CITY: WILDER STATE: KY ZIP: 41076 BUSINESS PHONE: 859-878-2220 MAIL ADDRESS: STREET 1: 1019 TOWN DRIVE CITY: WILDER STATE: KY ZIP: 41076 FORMER COMPANY: FORMER CONFORMED NAME: Protech Home Medical Corp. DATE OF NAME CHANGE: 20200714 FORMER COMPANY: FORMER CONFORMED NAME: Patient Home Monitoring Corp. DATE OF NAME CHANGE: 20120119 6-K 1 tm225093d1_6k.htm FORM 6-K

 

 

 

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549 

 

 

FORM 6-K 

 

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE 

SECURITIES EXCHANGE ACT OF 1934 

 

For the month of February 2022

 

Commission File Number: 001-40413 

 

 

Quipt Home Medical Corp. 

(Translation of registrant’s name into English)

 

 

1019 Town Drive 

Wilder, Kentucky 41076 

(Address of principal executive office) 

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F  ¨                Form 40-F  x

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ¨

 

 

 

 

 

 

EXHIBIT INDEX

 

Exhibit   Description
   
99.1   Material Change Report dated February 1, 2022
99.2   News Release dated January 31, 2022

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Quipt Home Medical Corp.
   
Date: February 2, 2022 /s/ Gregory Crawford
  Chief Executive Officer

 

 

 

 EX-99.1 2 tm225093d1_ex99-1.htm EXHIBIT 99.1

 

Exhibit 99.1

 

FORM 51-102F3 

MATERIAL CHANGE REPORT

 

1.Name and Address of Company

 

Quipt Home Medical Corp. (the "Company") 

1019 Town Drive 

Wilder, Kentucky 41076

 

2.Date of Material Change

 

January 28, 2022

 

3.News Release

 

A press release disclosing the material change was released on January 31, 2022 through GlobeNewswire.

 

4.Summary of Material Change

 

The management cease trade order issued by the British Columbia Securities Commission (“BCSC”) on ‎December 30, 2021 was revoked.‎

 

5.Full Description of Material Change

 

5.1Full Description of Material Change

 

As a result of the filing of its annual financial statements and management ‎discussion & analysis for the financial years ended September 30, 2021 and 2020, and the CEO and CFO ‎certificates, on January 28, 2022, the management cease trade order issued by the BCSC on December 30, 2021 was revoked by the BCSC effective January 28, 2022.‎

 

5.2Disclosure for Restructuring Transactions

 

Not applicable.

 

6.Reliance on subsection 7.1(2) of National Instrument 51-102

 

Not applicable.

 

7.Omitted Information

 

Not applicable.

 

8.Executive Officer

 

For additional information, please contact Hardik Mehta, Chief Financial Officer of the Company, at ‎‎(859) 202-3085.‎

 

9.Date of Report

 

February 1, 2022.

 

 

 

 EX-99.2 3 tm225093d1_ex99-2.htm EXHIBIT 99.2

 

Exhibit 99.2

 

QUIPT ANNOUNCES REVOCATION OF MANAGEMENT CEASE TRADE ORDER

 

Cincinnati, Ohio – January 31, 2022 – Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, is pleased to announce that, as a result of the filing of its annual financial statements and management discussion & analysis for the financial years ended September 30, 2021 and 2020, and the CEO and CFO certificates, on January 27, 2022, the management cease trade order issued by the British Columbia Securities Commission (“BCSC”) on December 30, 2021 has been revoked by the BCSC effective January 28, 2022.

 

ABOUT QUIPT HOME MEDICAL CORP.

 

The Company provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare market. It seeks to continue to expand its offerings to include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility and other chronic health conditions. The primary business objective of the Company is to create shareholder value by offering a broader range of services to patients in need of in-home monitoring and chronic disease management. The Company’s organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient’s services, and making life easier for the patient.

 

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

 

For further information please visit our website at www.Quipthomemedical.com, or contact:

 

Cole Stevens 

VP of Corporate Development 

Quipt Home Medical Corp. 

859-300-6455 

cole.stevens@myquipt.com

 

Gregory Crawford 

Chief Executive Officer 

Quipt Home Medical Corp. 

859-300-6455 

investorinfo@myquipt.com